| | |
| Supporting Information May Be Requested for Selected Patients with Adverse Events Potentially Related to Yellow Fever Vaccine (Information for doctors/clinicians) As a component of an enhanced surveillance program (See MMWR 2001; 50:343-5 and YF Vaccine and Severe Adverse Events) for adverse events potentially related to yellow fever vaccination, healthcare providers may be requested to provide additional clinical information for selected patients. The requested supporting information will be used to interpret serologic tests, assess underlying host factors, and seek reports of adverse events in other persons who received doses from the same lot of yellow fever vaccine. Supporting information that may be requested for selected patients: | |
| 1. | International travel history (with special attention to Africa and South America, where yellow fever is present) | |||||||
| 2. | Prior documented flaviviral infections (e.g., dengue, yellow fever, West Nile virus, Japanese encephalitis, St. Louis encephalitis, tickborne encephalitis) | |||||||
| 3. | Prior flaviviral vaccinations (yellow fever, Japanese encephalitis, or tickborne encephalitis vaccines) | |||||||
| 4. | History of immunosuppression (including malignancy, HIV, or organ transplant), autoimmune disorders (including systemic lupus erythematosus, rheumatoid arthritis, or vasculitis), ulcerative colitis, or Crohn’s disease/TD>| | 5. |
Medications in the past month (with special attention to corticosteriods and immunosuppressants) | | 6. |
Febrile illnesses observed in other recipients of yellow fever vaccine (with special attention to persons who received doses from the same vaccine lot as the initially reported patient) | |
| When necessary, this supporting information will be requested by reporting form. Back |